Moderna bivalent COVID booster vaccine gets interim nod in Singapore
Advertisement
Singapore: Singapore on Wednesday granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a statement.
The vaccine has been authorised for use as a booster shot in individuals aged 18 years and above who have received the primary series of COVID-19 vaccinations, the city-state's Health Sciences Authority said.
Moderna's bivalent vaccine contains mRNA designed to target two different coronavirus variants - the original variant from 2020 and the Omicron variant that was circulating widely last winter.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.